XML 50 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
In Millions, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Assets    
Cash and cash equivalents $ 974us-gaap_CashAndCashEquivalentsAtCarryingValue $ 192us-gaap_CashAndCashEquivalentsAtCarryingValue
Accounts receivable, net of allowance for doubtful accounts of $257 and $250 at March 31, 2015 and December 31, 2014, respectively 949us-gaap_AccountsReceivableNetCurrent 932us-gaap_AccountsReceivableNetCurrent
Inventories 106us-gaap_InventoryNet 110us-gaap_InventoryNet
Deferred income taxes 158us-gaap_DeferredTaxAssetsNetCurrent 169us-gaap_DeferredTaxAssetsNetCurrent
Prepaid expenses and other current assets 188us-gaap_PrepaidExpenseAndOtherAssetsCurrent 200us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 2,375us-gaap_AssetsCurrent 1,603us-gaap_AssetsCurrent
Property, plant and equipment, net 902us-gaap_PropertyPlantAndEquipmentNet 933us-gaap_PropertyPlantAndEquipmentNet
Goodwill 5,986us-gaap_Goodwill 6,032us-gaap_Goodwill
Intangible assets, net 1,041us-gaap_IntangibleAssetsNetExcludingGoodwill 1,071us-gaap_IntangibleAssetsNetExcludingGoodwill
Other assets 254us-gaap_OtherAssetsNoncurrent 238us-gaap_OtherAssetsNoncurrent
Non-current assets held for sale 55us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent 0us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
Total assets 10,613us-gaap_Assets 9,877us-gaap_Assets
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,046us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent 1,191us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Current portion of long-term debt 1,043us-gaap_DebtCurrent 518us-gaap_DebtCurrent
Total current liabilities 2,089us-gaap_LiabilitiesCurrent 1,709us-gaap_LiabilitiesCurrent
Long-term debt 3,688us-gaap_LongTermDebtAndCapitalLeaseObligations 3,244us-gaap_LongTermDebtAndCapitalLeaseObligations
Other liabilities 565us-gaap_OtherLiabilitiesNoncurrent 594us-gaap_OtherLiabilitiesNoncurrent
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized at both March 31, 2015 and December 31, 2014; 216 shares and 215 shares issued at March 31, 2015 and December 31, 2014, respectively 2us-gaap_CommonStockValue 2us-gaap_CommonStockValue
Additional paid-in capital 2,427us-gaap_AdditionalPaidInCapitalCommonStock 2,418us-gaap_AdditionalPaidInCapitalCommonStock
Retained earnings 5,729us-gaap_RetainedEarningsAccumulatedDeficit 5,723us-gaap_RetainedEarningsAccumulatedDeficit
Accumulated other comprehensive loss (30)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (27)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Treasury stock, at cost; 72 shares and 71 shares at March 31, 2015 and December 31, 2014 (3,885)us-gaap_TreasuryStockValue (3,815)us-gaap_TreasuryStockValue
Total Quest Diagnostics stockholders' equity 4,243us-gaap_StockholdersEquity 4,301us-gaap_StockholdersEquity
Noncontrolling interests 28us-gaap_MinorityInterest 29us-gaap_MinorityInterest
Total stockholders' equity 4,271us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 4,330us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total liabilities and stockholders' equity $ 10,613us-gaap_LiabilitiesAndStockholdersEquity $ 9,877us-gaap_LiabilitiesAndStockholdersEquity